Exelon Corp. shares traded steadily on Nasdaq, aligning with the broader U.S. utilities sector, as investors anticipated earnings reports and monitored interest-rate expectations impacting regulated power companies. The company, with a market capitalization around $51.26 billion, operates regulated electric and gas utilities across several U.S. regions, deriving revenue from tariff structures. Exelon is positioned as a significant player in the U.S. utilities landscape, often grouped with large regulated names like NextEra Energy and Duke Energy due to its defensive characteristics and stable dividend profile.

Hilton is expanding its presence in the Florida Keys with the upcoming conversion of Ocean’s Edge Resort & Marina to Hilton Key West Resort & Marina, accepting reservations for stays beginning July 1, 2026. The 175-room waterfront resort on Stock Island will feature numerous amenities including 86 suites, private balconies, marina access, six saltwater pools, and destination dining. This expansion aims to provide a full-service Keys experience combined with Hilton's renowned hospitality and the benefits of the Hilton Honors program.

Uber Technologies Inc. is cutting 23% of jobs in its People and Places division, which includes human resources and recruitment. This move, spearheaded by newly promoted president Jill Hazelbaker, aims to simplify the team structure. The cuts primarily affect senior roles, but represent less than 1% of Uber's total 34,000 employees globally.

Veteran strategist Ed Yardeni of Yardeni Research is predicting a Federal Reserve interest rate hike as early as their July 29 meeting, contrary to the broader market consensus which anticipates rates to remain unchanged. His forecast is based on a resilient economy, firm labor market, and rising inflation driven by increasing energy costs. Despite this hawkish outlook, Yardeni maintains a bullish stance on the stock market, forecasting the S&P 500 to reach 8,250 by year-end due to strong earnings momentum.

Billionaire investor Stanley Druckenmiller is known for favoring asymmetric bets, where the potential upside significantly outweighs the downside. This article highlights five non-AI stocks that Druckenmiller has invested in, focusing on companies with unique market positions or innovative products. One example is NewAmsterdam Pharma (NASDAQ:NAMS), a biotech company developing an oral drug to lower cholesterol, addressing a significant unmet medical need despite its inherent risks.

Moody's has downgraded NiSource Inc.'s senior unsecured debt rating to Baa3 with a negative outlook, citing high leverage and weaker cash flow metrics, though the stock remained steady on the NYSE. Despite concerns, NiSource maintains an investment-grade rating and access to capital, with its valuation and dividend yield comparable to peers like Atmos Energy and CenterPoint Energy. The downgrade highlights the ongoing focus on the company's debt load and funding needs for credit analysts and market participants.

Henry Fernandez, CEO of NYSE-listed financial company MSCI, has purchased a Palm Beach mansion for $25 million. The article includes photos of the property located at 134 Casa Bendita. This acquisition highlights ongoing high-value real estate transactions in the South Florida area.

Texas Pacific Land Corporation (TPL) saw its stock surge by 6.1% on Wednesday, closing at $393.57, amid a broad rally impacting oil and gas exploration and production companies. The increase was not company-specific but rather part of a sector-wide advance. Investors are likely responding to favorable market dynamics for the energy sector, and the company's market capitalization now stands at $27.1 billion.

Olin Corp (OLN) executive Florian J. Kohl exercised 1,250 restricted stock units (RSUs), converting them into common shares. To cover tax obligations, 492 of these common shares were withheld in a disposition transaction. After these transactions, Kohl directly holds 8,441 common shares and 2,500 RSUs remaining to vest by June 1, 2027.

Insulet Corporation has launched significant enhancements for its Omnipod 5 Automated Insulin Delivery (AID) System, including a new 100 mg/dL target glucose option for hyper-personalization and expanded compatibility with Abbott’s FreeStyle Libre 3 Plus sensor. These updates aim to improve glycemic control, enhance user experience by reducing alarm fatigue, and strengthen Insulet's position in the competitive diabetes technology market through a platform-agnostic strategy. The company is actively building a connected, user-centric health ecosystem while addressing operational complexities.